glp-1 and alcoholism GLP-1s tied to lower alcohol intake for adults with overweight, obesity GLP-1 receptor agonists for the
Description
Three new studies suggest GLP-1 drugs may reduce cancer risk and improve outcomes.
There is limited real-world data evaluating outcomes of glucagon-like peptide-1 receptor agonists (GLP1-RA) use in patients with moderate to advanced CKD
Do GLP-1 medications make you thirsty
For the first time ever, Medicare will cover medications for weight loss, through a new program launched this month
